95 related articles for article (PubMed ID: 12657903)
21. N-methyl-D-aspartate induces phase shifts in circadian rhythm of neuronal activity of rat SCN in vitro.
Shibata S; Watanabe A; Hamada T; Ono M; Watanabe S
Am J Physiol; 1994 Aug; 267(2 Pt 2):R360-4. PubMed ID: 7520671
[TBL] [Abstract][Full Text] [Related]
22. Regulation of light's action in the mammalian circadian clock: role of the extrasynaptic GABAA receptor.
Ehlen JC; Paul KN
Am J Physiol Regul Integr Comp Physiol; 2009 May; 296(5):R1606-12. PubMed ID: 19244580
[TBL] [Abstract][Full Text] [Related]
23. GABAA receptor agonist muscimol can reset the phase of neural activity rhythm in the rat suprachiasmatic nucleus in vitro.
Tominaga K; Shibata S; Hamada T; Watanabe S
Neurosci Lett; 1994 Jan; 166(1):81-4. PubMed ID: 8190363
[TBL] [Abstract][Full Text] [Related]
24. Enhancement of photic shifts with the 5-HT1A mixed agonist/antagonist NAN-190: intra-suprachiasmatic nucleus pathway.
Sterniczuk R; Stepkowski A; Jones M; Antle MC
Neuroscience; 2008 May; 153(3):571-80. PubMed ID: 18406538
[TBL] [Abstract][Full Text] [Related]
25. N-Methyl-D-aspartate microinjected into the suprachiasmatic nucleus mimics the phase-shifting effects of light in the diurnal Nile grass rat (Arvicanthis niloticus).
Novak CM; Albers HE
Brain Res; 2002 Oct; 951(2):255-63. PubMed ID: 12270504
[TBL] [Abstract][Full Text] [Related]
26. On the intrinsic regulation of neuropeptide Y release in the mammalian suprachiasmatic nucleus circadian clock.
Glass JD; Guinn J; Kaur G; Francl JM
Eur J Neurosci; 2010 Mar; 31(6):1117-26. PubMed ID: 20377624
[TBL] [Abstract][Full Text] [Related]
27. Transduction of light in the suprachiasmatic nucleus: evidence for two different neurochemical cascades regulating the levels of Per1 mRNA and pineal melatonin.
Paul KN; Fukuhara C; Tosini G; Albers HE
Neuroscience; 2003; 119(1):137-44. PubMed ID: 12763075
[TBL] [Abstract][Full Text] [Related]
28. Effects of inhibitory and excitatory drugs on the metabolic rhythm of the hamster suprachiasmatic nucleus in vitro.
Tominaga K; Shibata S; Ueki S; Watanabe S
Eur J Pharmacol; 1992 Jun; 217(1):79-84. PubMed ID: 1356802
[TBL] [Abstract][Full Text] [Related]
29. Novel phase-shifting effects of GABAA receptor activation in the suprachiasmatic nucleus of a diurnal rodent.
Novak CM; Albers HE
Am J Physiol Regul Integr Comp Physiol; 2004 May; 286(5):R820-5. PubMed ID: 14656771
[TBL] [Abstract][Full Text] [Related]
30. Serotonergic serotonin (1A) mixed agonists/antagonists elicit large-magnitude phase shifts in hamster circadian wheel-running rhythms.
Gannon RL
Neuroscience; 2003; 119(2):567-76. PubMed ID: 12770569
[TBL] [Abstract][Full Text] [Related]
31. NMDA induced glutamate release from the suprachiasmatic nucleus: an in vitro study in the rat.
Hamada T; Sonoda R; Watanabe A; Ono M; Shibata S; Watanabe S
Neurosci Lett; 1998 Nov; 256(2):93-6. PubMed ID: 9853711
[TBL] [Abstract][Full Text] [Related]
32. An NMDA antagonist inhibits light but not GRP-induced phase shifts when administered after the phase-shifting stimulus.
Kallingal GJ; Mintz EM
Brain Res; 2010 Sep; 1353():106-12. PubMed ID: 20682305
[TBL] [Abstract][Full Text] [Related]
33. Bicuculline increases and muscimol reduces the phase-delaying effects of light and VIP/PHI/GRP in the suprachiasmatic region.
Gillespie CF; Huhman KL; Babagbemi TO; Albers HE
J Biol Rhythms; 1996 Jun; 11(2):137-44. PubMed ID: 8744241
[TBL] [Abstract][Full Text] [Related]
34. NMDA and PACAP receptor signaling interact to mediate retinal-induced scn cellular rhythmicity in the absence of light.
Webb IC; Coolen LM; Lehman MN
PLoS One; 2013; 8(10):e76365. PubMed ID: 24098484
[TBL] [Abstract][Full Text] [Related]
35. GABAergic regulation of light-induced c-Fos immunoreactivity within the suprachiasmatic nucleus.
Gillespie CF; Van Der Beek EM; Mintz EM; Mickley NC; Jasnow AM; Huhman KL; Albers HE
J Comp Neurol; 1999 Sep; 411(4):683-92. PubMed ID: 10421877
[TBL] [Abstract][Full Text] [Related]
36. GABA(B) receptor activation in the suprachiasmatic nucleus of diurnal and nocturnal rodents.
Novak CM; Ehlen JC; Huhman KL; Albers HE
Brain Res Bull; 2004 Jul; 63(6):531-5. PubMed ID: 15249119
[TBL] [Abstract][Full Text] [Related]
37. Positive and negative modulation of circadian activity rhythms by mGluR5 and mGluR2/3 metabotropic glutamate receptors.
Gannon RL; Millan MJ
Neuropharmacology; 2011; 60(2-3):209-15. PubMed ID: 20831878
[TBL] [Abstract][Full Text] [Related]
38. Further evaluation of the tetrodotoxin-resistant circadian pacemaker in the suprachiasmatic nuclei.
Schwartz WJ
J Biol Rhythms; 1991; 6(2):149-58. PubMed ID: 1663409
[TBL] [Abstract][Full Text] [Related]
39. Copper chelation and exogenous copper affect circadian clock phase resetting in the suprachiasmatic nucleus in vitro.
Yamada Y; Prosser RA
Neuroscience; 2014 Jan; 256():252-61. PubMed ID: 24161278
[TBL] [Abstract][Full Text] [Related]
40. Facilitation of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor transmission in the suprachiasmatic nucleus by aniracetam enhances photic responses of the biological clock in rodents.
Moriya T; Ikeda M; Teshima K; Hara R; Kuriyama K; Yoshioka T; Allen CN; Shibata S
J Neurochem; 2003 May; 85(4):978-87. PubMed ID: 12716429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
